Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-16
DOI
10.1038/s41467-018-05566-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulating IgG effector function by Fc glycan engineering
- (2017) Tiezheng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice
- (2016) Elisa A. Nigro et al. JOURNAL OF IMMUNOLOGY
- FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
- (2015) Rony Dahan et al. CANCER CELL
- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- Fcγ receptor pathways during active and passive immunization
- (2015) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
- (2015) Yaron Carmi et al. NATURE
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- Classical Flt3L-dependent dendritic cells control immunity to protein vaccine
- (2014) Niroshana Anandasabapathy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane
- (2014) Maria Luisa Guzmán-Hernández et al. MOLECULAR BIOLOGY OF THE CELL
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
- (2014) Jiehua Zhou et al. Molecular Therapy-Nucleic Acids
- Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
- (2013) Yannick Bulliard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD8+ T Cell-Independent Tumor Regression Induced by Fc-OX40L and Therapeutic Vaccination in a Mouse Model of Glioma
- (2013) K. A. Murphy et al. JOURNAL OF IMMUNOLOGY
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
- (2012) Mark P Chao et al. CURRENT OPINION IN IMMUNOLOGY
- Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
- (2011) Marion G. Ott et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
- (2010) R. Abes et al. BLOOD
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
- (2009) S. P. Hilchey et al. BLOOD
- Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
- (2009) Ussama M. Abdel-Motal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Antitumor IgE Adjuvanticity: Key Role of Fc RI
- (2009) E. A. Nigro et al. JOURNAL OF IMMUNOLOGY
- RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells
- (2008) Zhiyong Mi et al. MOLECULAR THERAPY
- The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
- (2007) Bruce A. Macher et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now